OXA®
Brand Name: OXA®
Composition (Active Ingredient): Oxaliplatin Injection USP
Manufacturer: Emcure®
Volume / Strength: 50 mg / 25 ml (25 ml total volume)
Product Description
Medical Info
OXA® is a specialized oncological formulation developed by Emcure®, containing Oxaliplatin Injection USP (50 mg/25 ml). As a platinum-based chemotherapy medication, it is primarily prescribed in combination regimens for the treatment of advanced colorectal cancer. It functions by inhibiting DNA replication in rapidly dividing cancer cells, effectively slowing or halting tumor progression. Given its critical role in oncology, OXA® must be prepared and administered exclusively via intravenous infusion under the direct supervision of a qualified healthcare professional in a specialized clinical setting. Always monitor patient parameters closely during therapy.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
